Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Olivier

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
European Urology|November 29, 2022
Re: Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerArnauld Villers, Jonathan Olivier
European Urology|May 12, 2020
Re: Long-term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center ExperienceArnauld Villers, Jonathan Olivier
European Urology|April 14, 2018
Re: Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance OutcomesArnauld Villers, Jonathan Olivier
The Journal of Urology|June 27, 2020
Editorial CommentArnauld Villers, Jonathan Olivier
BJU International|October 19, 2025
Re: quantifying Gleason pattern 4: the multifocality blind spot in prognostic modelsAndrew Vickers, Arnauld Villers, Jonathan Olivier
World Journal of Urology|September 15, 2023
Standardized reports of focal-HIFU results is paramount: a closer look at the Duwe et al.'s cohort on focal HIFU for localized prostate cancerDenis Séguier, Arnauld Villers, Jonathan Olivier
Diagnostic and Interventional Imaging|May 23, 2025
Focal Laser ablation in prostate diseases: Consolidating evidence and navigating future directionsDenis Séguier, Jonathan Olivier, Arnauld Villers
European Urology Open Science|September 1, 2021
TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate-NoJonathan Olivier, Badrinath Konety, Dickon Hayne
Frontiers in Oncology|July 22, 2022
Editorial: Precision Medicine and Translational Research in Urological OncologyRong Na, Jonathan Olivier, Gong-Hong Wei
The French Journal of Urology|July 27, 2025
Prescribing androgen deprivation therapy for prostate cancer: Results of a French questionnaire surveyThéophile Pajot, Jonathan Olivier, Denis Séguier, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
European Urology|November 29, 2022
Re: Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerArnauld Villers, Jonathan Olivier
European Urology|May 12, 2020
Re: Long-term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center ExperienceArnauld Villers, Jonathan Olivier
European Urology|April 14, 2018
Re: Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance OutcomesArnauld Villers, Jonathan Olivier
The Journal of Urology|June 27, 2020
Editorial CommentArnauld Villers, Jonathan Olivier
BJU International|October 19, 2025
Re: quantifying Gleason pattern 4: the multifocality blind spot in prognostic modelsAndrew Vickers, Arnauld Villers, Jonathan Olivier
World Journal of Urology|September 15, 2023
Standardized reports of focal-HIFU results is paramount: a closer look at the Duwe et al.'s cohort on focal HIFU for localized prostate cancerDenis Séguier, Arnauld Villers, Jonathan Olivier
Diagnostic and Interventional Imaging|May 23, 2025
Focal Laser ablation in prostate diseases: Consolidating evidence and navigating future directionsDenis Séguier, Jonathan Olivier, Arnauld Villers
European Urology Open Science|September 1, 2021
TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate-NoJonathan Olivier, Badrinath Konety, Dickon Hayne
Frontiers in Oncology|July 22, 2022
Editorial: Precision Medicine and Translational Research in Urological OncologyRong Na, Jonathan Olivier, Gong-Hong Wei
The French Journal of Urology|July 27, 2025
Prescribing androgen deprivation therapy for prostate cancer: Results of a French questionnaire surveyThéophile Pajot, Jonathan Olivier, Denis Séguier, et al.
Pageof 10